|
ZNF664 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.382800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.165500E-04 |
| Normal-vs-Stage2 |
3.069400E-01 |
| Normal-vs-Stage3 |
7.87970000000193E-05 |
| Normal-vs-Stage4 |
1.24659999989341E-07 |
| Stage1-vs-Stage2 |
3.878900E-03 |
| Stage1-vs-Stage3 |
1.540580E-01 |
| Stage1-vs-Stage4 |
3.422800E-03 |
| Stage2-vs-Stage3 |
6.019900E-04 |
| Stage2-vs-Stage4 |
5.74340000000229E-05 |
| Stage3-vs-Stage4 |
1.990030E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36239999999999E-05 |
| Normal-vs-AfricanAmerican |
1.244050E-02 |
| Normal-vs-Asian |
4.397700E-04 |
| Caucasian-vs-AfricanAmerican |
7.060200E-01 |
| Caucasian-vs-Asian |
7.903000E-01 |
| AfricanAmerican-vs-Asian |
6.217600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.364600E-04 |
| Normal-vs-Female |
1.362660E-03 |
| Male-vs-Female |
2.139200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.582900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.335480E-03 |
| Normal-vs-Age(61-80Yrs) |
4.280500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.660540E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.869200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.759040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.057800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.642200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.448200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.165250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.616100E-03 |
| Classical-VS-Follicular |
3.23680000025028E-07 |
| Classical-VS-Other |
4.439000E-01 |
| Classical-VS-Normal |
1.24369999998653E-06 |
| Tall-VS-Follicular |
1.25790000637949E-09 |
| Tall-VS-Other |
7.427200E-01 |
| Tall-VS-Normal |
3.67219998853585E-09 |
| Follicular-VS-Other |
4.370700E-04 |
| Follicular-VS-Normal |
1.009620E-01 |
| Other-VS-Normal |
5.843700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.383700E-02 |
| Normal-vs-N1 |
2.54190002380028E-09 |
| N0-vs-N1 |
7.72279999949887E-07 |
|
|
